| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |